Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.
Rob L, Cibula D, Knapp P, Mallmann P, Klat J, Minar L, Bartos P, Chovanec J, Valha P, Pluta M, Novotny Z, Spacek J, Melichar B, Kieszko D, Fucikova J, Hrnciarova T, Korolkiewicz RP, Hraska M, Bartunkova J, Spisek R. Rob L, et al. Among authors: pluta m. J Immunother Cancer. 2022 Jan;10(1):e003190. doi: 10.1136/jitc-2021-003190. J Immunother Cancer. 2022. PMID: 34992091 Free PMC article. Clinical Trial.
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.
Cibula D, Rob L, Mallmann P, Knapp P, Klat J, Chovanec J, Minar L, Melichar B, Hein A, Kieszko D, Pluta M, Spacek J, Bartos P, Wimberger P, Madry R, Markowska J, Streb J, Valha P, Hassan HIB, Pecen L, Galluzzi L, Fucikova J, Hrnciarova T, Hraska M, Bartunkova J, Spisek R. Cibula D, et al. Among authors: pluta m. Gynecol Oncol. 2021 Sep;162(3):652-660. doi: 10.1016/j.ygyno.2021.07.003. Epub 2021 Jul 20. Gynecol Oncol. 2021. PMID: 34294416 Free article. Clinical Trial.
Advances in fertility-sparing surgery for cervical cancer.
Rob L, Pluta M, Skapa P, Robova H. Rob L, et al. Among authors: pluta m. Expert Rev Anticancer Ther. 2010 Jul;10(7):1101-14. doi: 10.1586/era.10.61. Expert Rev Anticancer Ther. 2010. PMID: 20645699 Review.
The role of neoadjuvant chemotherapy and surgery in cervical cancer.
Robova H, Halaska M, Pluta M, Skapa P, Strnad P, Lisy J, Rob L. Robova H, et al. Among authors: pluta m. Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S42-6. doi: 10.1111/igc.0b013e3181f60d73. Int J Gynecol Cancer. 2010. PMID: 21053526 Review.
[Treatment of recurrent ovarian cancer].
Robová H, Rob L, Pluta M, Halaska M Jr, Chmel R. Robová H, et al. Among authors: pluta m. Ceska Gynekol. 2009 Dec;74(6):464-8. Ceska Gynekol. 2009. PMID: 21246797 Review. Czech.
The role of trachelectomy in cervical cancer.
Halaska M, Robova H, Pluta M, Rob L. Halaska M, et al. Among authors: pluta m. Ecancermedicalscience. 2015 Feb 3;9:506. doi: 10.3332/ecancer.2015.506. eCollection 2015. Ecancermedicalscience. 2015. PMID: 25729419 Free PMC article. Review.
141 results